| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |